Korean Firm, Asia’s First to Get FDA Clearance for Testing Anti-Cancer Microbiome Therapeutic
By Judy Ya-Hsuan Lin Genome & Company, a clinical-stage biotech headquartered in South Korea, announces a key milestone for its first anti-cancer microbiome therapeutic, GEN-001. On April 20th this year, …
Read More